Revision of a method quality rating scale for single-case experimental designs and n-of-1 trials: The 15-item Risk of Bias in N-of-1 Trials (RoBiNT) Scale

Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-c...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychological rehabilitation Vol. 23; no. 5; pp. 619 - 638
Main Authors Tate, Robyn L, Perdices, Michael, Rosenkoetter, Ulrike, Wakim, Donna, Godbee, Kali, Togher, Leanne, McDonald, Skye
Format Journal Article
LanguageEnglish
Published Hove Routledge 01.10.2013
Psychology Press
Taylor & Francis Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC TotalScore  = .90, ICC IVSubscale  = .88, ICC EVISubscale  = .87; individual (novice) raters: ICC TotalScore  = .88, ICC IVSubscale  = .87, ICC EVISubscale  = .93; consensus ratings between experienced and novice raters (ICC TotalScore  = .95, ICC IVSubscale  = .93, ICC EVISubscale  = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology.
AbstractList Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC(TotalScore) = .90, ICC(IVSubscale) = .88, ICC(EVISubscale) = .87; individual (novice) raters: ICC(TotalScore)= .88, ICC(IVSubscale) = .87, ICC(EVISubscale) = .93; consensus ratings between experienced and novice raters (ICC(TotalScore) = .95, ICC(IVSubscale) = .93, ICC(EVISubscale) = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology.Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC(TotalScore) = .90, ICC(IVSubscale) = .88, ICC(EVISubscale) = .87; individual (novice) raters: ICC(TotalScore)= .88, ICC(IVSubscale) = .87, ICC(EVISubscale) = .93; consensus ratings between experienced and novice raters (ICC(TotalScore) = .95, ICC(IVSubscale) = .93, ICC(EVISubscale) = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology.
Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICCTotalScore = .90, ICCIVSubscale = .88, ICCEVISubscale = .87; individual (novice) raters: ICCTotalScore = .88, ICCIVSubscale = .87, ICCEVISubscale = .93; consensus ratings between experienced and novice raters (ICCTotalScore = .95, ICCIVSubscale = .93, ICCEVISubscale = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology. Adapted from the source document.
Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICCTotalScore = .90, ICCIVSubscale = .88, ICCEVISubscale = .87; individual (novice) raters: ICCTotalScore = .88, ICCIVSubscale = .87, ICCEVISubscale = .93; consensus ratings between experienced and novice raters (ICCTotalScore = .95, ICCIVSubscale = .93, ICCEVISubscale = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology. [PUBLICATION ABSTRACT]
Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC TotalScore  = .90, ICC IVSubscale  = .88, ICC EVISubscale  = .87; individual (novice) raters: ICC TotalScore  = .88, ICC IVSubscale  = .87, ICC EVISubscale  = .93; consensus ratings between experienced and novice raters (ICC TotalScore  = .95, ICC IVSubscale  = .93, ICC EVISubscale  = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology.
Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC sub(TotalScore) = .90, ICC sub(IVSubscale) = .88, ICC sub(EVISubscale) = .87; individual (novice) raters: ICC sub(TotalScore) = .88, ICC sub(IVSubscale) = .87, ICC sub(EVISubscale) = .93; consensus ratings between experienced and novice raters (ICC sub(TotalScore) = .95, ICC sub(IVSubscale) = .93, ICC sub(EVISubscale) = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology.
Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment decision purposes by the Oxford Centre for Evidence-Based Medicine). Consequently, the availability of tools to critically appraise single-case reports is of great importance. We report on a major revision of our method quality instrument, the Single-Case Experimental Design Scale. Three changes resulted in a radically revised instrument, now entitled the Risk of Bias in N-of-1 Trials (RoBiNT) Scale: (i) item content was revised and increased to 15 items, (ii) two subscales were developed for internal validity (IV; 7 items) and external validity and interpretation (EVI; 8 items), and (iii) the scoring system was changed from a 2-point to 3-point scale to accommodate currently accepted standards. Psychometric evaluation indicated that the RoBiNT Scale showed evidence of construct (discriminative) validity. Inter-rater reliability was excellent, for pairs of both experienced and trained novice raters. Intraclass correlation coefficients of summary scores for individual (experienced) raters: ICC(TotalScore) = .90, ICC(IVSubscale) = .88, ICC(EVISubscale) = .87; individual (novice) raters: ICC(TotalScore)= .88, ICC(IVSubscale) = .87, ICC(EVISubscale) = .93; consensus ratings between experienced and novice raters (ICC(TotalScore) = .95, ICC(IVSubscale) = .93, ICC(EVISubscale) = .93. The RoBiNT Scale thus shows sound psychometric properties and provides a comprehensive yet efficient examination of important features of single-case methodology.
Author McDonald, Skye
Tate, Robyn L
Godbee, Kali
Wakim, Donna
Perdices, Michael
Togher, Leanne
Rosenkoetter, Ulrike
Author_xml – sequence: 1
  givenname: Robyn L
  surname: Tate
  fullname: Tate, Robyn L
  email: rtate@med.usyd.edu.au
  organization: Royal Rehabilitation Centre Sydney
– sequence: 2
  givenname: Michael
  surname: Perdices
  fullname: Perdices, Michael
  organization: Department of Psychological Medicine , University of Sydney
– sequence: 3
  givenname: Ulrike
  surname: Rosenkoetter
  fullname: Rosenkoetter, Ulrike
  organization: Rehabilitation Studies Unit, Sydney Medical School - Northern , University of Sydney
– sequence: 4
  givenname: Donna
  surname: Wakim
  fullname: Wakim, Donna
  organization: Rehabilitation Studies Unit, Sydney Medical School - Northern , University of Sydney
– sequence: 5
  givenname: Kali
  surname: Godbee
  fullname: Godbee, Kali
  organization: Rehabilitation Studies Unit, Sydney Medical School - Northern , University of Sydney
– sequence: 6
  givenname: Leanne
  surname: Togher
  fullname: Togher, Leanne
  organization: Speech Pathology, Faculty of Health Sciences , University of Sydney
– sequence: 7
  givenname: Skye
  surname: McDonald
  fullname: McDonald, Skye
  organization: School of Psychology , University of New South Wales
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27801078$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24050810$$D View this record in MEDLINE/PubMed
BookMark eNqN0s1u1DAQB3ALFdFt4Q0QsoSQyiGLJ3ESpxdEK76kqkjLco689qR1Seyt7QX2VXhaHLILUg-US6Ikv7En4_8RObDOIiFPgc2BCfaKNRXLGcA8XYq5yHkhigdkBrziGasafkBmI8lGc0iOQrhhDATj1SNymHNWMgFsRn4u8JsJxlnqOirpgPHaaXq7kb2JW-plNPaKBiV7pJ3zNKTHHjMlA1L8sUZvBrRR9lRjMFc2UGk1tZnrMqDRG9mHU7q8RgplZiIOdGHC13GnMyMDNZZeTnT5m9KThTszl8uX9PO44WPysEtv8cnufky-vHu7PP-QXXx6__H8zUWmuKhjVlQgdK2A1byuamCybHiec-hQs6bDKmccNSolkReQvpS1Xq10VSjWlXmzaopjcjKtu_budoMhtoMJCvteWnSb0EIJOTQgGrifpuEnLUT5H7TgNU_NjQ08v0Nv3Mbb9M-TqhiHUT3bqc1qQN2u0-yl37b7s0zgxQ7I8cA6L60y4a-rBUtDEsnxySnvQvDY_SHA2jFa7T5a7RitdopWKju9U6ZMTPlwNnpp-vuKX0_FxqYYDfK7871uo9z2zu8bLf65wi_j5eEx
CODEN NREHE3
CitedBy_id crossref_primary_10_1016_j_apmr_2024_07_010
crossref_primary_10_1016_j_jpain_2023_03_013
crossref_primary_10_1080_02687038_2014_985884
crossref_primary_10_1212_WNL_0000000000011597
crossref_primary_10_2522_ptj_2016_96_7_e1
crossref_primary_10_1016_j_ridd_2018_03_003
crossref_primary_10_1186_s13643_017_0525_4
crossref_primary_10_1080_17437199_2017_1316672
crossref_primary_10_1080_09602011_2014_927368
crossref_primary_10_1080_09602011_2019_1696212
crossref_primary_10_1080_11038128_2024_2444591
crossref_primary_10_1177_0741932517729508
crossref_primary_10_1016_j_ebr_2024_100681
crossref_primary_10_1080_09602011_2023_2181191
crossref_primary_10_3758_s13428_023_02230_1
crossref_primary_10_3917_anpsy1_191_0055
crossref_primary_10_1016_j_arrct_2023_100260
crossref_primary_10_2196_48503
crossref_primary_10_1111_1460_6984_12942
crossref_primary_10_1002_jeab_799
crossref_primary_10_1016_j_jsp_2016_04_001
crossref_primary_10_1080_02699052_2018_1458335
crossref_primary_10_3390_cancers13215428
crossref_primary_10_3758_s13428_022_01858_9
crossref_primary_10_1016_j_anpsic_2017_05_004
crossref_primary_10_1089_neu_2022_0434
crossref_primary_10_1080_09602011_2016_1255230
crossref_primary_10_11124_JBIES_23_00139
crossref_primary_10_1186_s12984_020_00788_x
crossref_primary_10_1016_j_jvoice_2021_03_026
crossref_primary_10_1177_0008417416648124
crossref_primary_10_1080_09602011_2018_1485110
crossref_primary_10_1371_journal_pdig_0000183
crossref_primary_10_3109_17549507_2015_1024169
crossref_primary_10_1177_0141076817721131
crossref_primary_10_1016_j_beproc_2021_104461
crossref_primary_10_1044_2021_LSHSS_20_00005
crossref_primary_10_1080_02687038_2018_1491192
crossref_primary_10_1080_09602011_2018_1488746
crossref_primary_10_3390_jcm11102757
crossref_primary_10_1080_02699052_2020_1831072
crossref_primary_10_1080_09602011_2017_1365730
crossref_primary_10_3758_s13428_016_0714_4
crossref_primary_10_1080_09602011_2022_2114503
crossref_primary_10_3109_17549507_2015_1126640
crossref_primary_10_1177_0145445519863035
crossref_primary_10_1177_02711214241281383
crossref_primary_10_3389_fpsyg_2016_00032
crossref_primary_10_1016_j_ridd_2018_04_029
crossref_primary_10_1002_bin_1875
crossref_primary_10_1080_09362835_2016_1196441
crossref_primary_10_1007_s40474_023_00290_8
crossref_primary_10_1044_2024_AJSLP_24_00287
crossref_primary_10_1080_09602011_2022_2096080
crossref_primary_10_1111_dmcn_15759
crossref_primary_10_1177_20597991221077910
crossref_primary_10_1097_HTR_0000000000000795
crossref_primary_10_3389_fmed_2025_1493832
crossref_primary_10_1080_17489539_2020_1741842
crossref_primary_10_1111_dmcn_15513
crossref_primary_10_3758_s13428_018_1165_x
crossref_primary_10_1080_09602011_2016_1270837
crossref_primary_10_1177_0145445515603706
crossref_primary_10_1080_17489539_2022_2139148
crossref_primary_10_1111_bjet_13468
crossref_primary_10_5334_pb_1307
crossref_primary_10_1044_2024_JSLHR_23_00026
crossref_primary_10_1186_s12883_024_03699_9
crossref_primary_10_1080_09602011_2019_1653936
crossref_primary_10_1017_BrImp_2021_32
crossref_primary_10_1002_eat_22887
crossref_primary_10_1177_0741932517726143
crossref_primary_10_3390_healthcare7040143
crossref_primary_10_1016_j_beth_2024_01_008
crossref_primary_10_1007_s40614_021_00289_9
crossref_primary_10_1159_000505265
crossref_primary_10_1017_S1352465822000224
crossref_primary_10_1186_s13643_021_01589_6
crossref_primary_10_5014_ajot_2016_704002
crossref_primary_10_1044_2014_AJSLP_13_0035
crossref_primary_10_1080_09638288_2023_2221459
crossref_primary_10_2106_JBJS_RVW_23_00077
crossref_primary_10_1016_j_brat_2019_01_005
crossref_primary_10_1186_s13643_023_02255_9
crossref_primary_10_1080_09602011_2014_903198
crossref_primary_10_1080_09602011_2014_903199
crossref_primary_10_1080_09602011_2015_1064452
crossref_primary_10_1080_09602011_2017_1310658
crossref_primary_10_1017_BrImp_2022_32
crossref_primary_10_1080_09602011_2016_1190533
crossref_primary_10_1026_1616_3443_a000665
crossref_primary_10_1186_s40814_022_01153_6
crossref_primary_10_1080_09602011_2024_2345410
crossref_primary_10_1186_s12887_023_04189_6
crossref_primary_10_1177_02692155231218813
crossref_primary_10_3758_s13428_023_02303_1
crossref_primary_10_1007_s10578_021_01237_z
crossref_primary_10_1016_j_jbct_2024_100502
crossref_primary_10_1177_0145445519837726
crossref_primary_10_1002_jcv2_12181
crossref_primary_10_1212_WNL_0000000000012998
crossref_primary_10_1080_02687038_2014_987051
crossref_primary_10_1186_s13023_023_02756_9
crossref_primary_10_1080_02687038_2014_1000613
crossref_primary_10_1038_s41393_024_01057_7
crossref_primary_10_1080_02699052_2019_1631482
crossref_primary_10_1080_07317115_2025_2481124
crossref_primary_10_1186_s13047_020_00400_4
crossref_primary_10_1016_j_jcbs_2021_05_005
crossref_primary_10_1044_2023_JSLHR_22_00665
crossref_primary_10_1186_s12879_023_08304_x
crossref_primary_10_1080_17483107_2019_1604828
crossref_primary_10_1111_bph_16100
crossref_primary_10_1017_BrImp_2017_17
crossref_primary_10_1017_BrImp_2017_16
crossref_primary_10_2196_16066
crossref_primary_10_1038_s41572_018_0052_1
crossref_primary_10_1016_j_jclinepi_2024_111460
crossref_primary_10_1186_s12888_023_05422_3
crossref_primary_10_1016_j_jclinepi_2016_04_006
crossref_primary_10_1136_bmjopen_2024_089319
crossref_primary_10_3233_PRM_230019
crossref_primary_10_1111_epi_18068
crossref_primary_10_1007_s10880_019_09620_8
crossref_primary_10_1016_j_jphys_2020_06_004
crossref_primary_10_1080_17489539_2019_1645982
crossref_primary_10_1017_BrImp_2017_25
crossref_primary_10_1080_09602011_2014_915856
crossref_primary_10_1007_s40489_016_0091_z
crossref_primary_10_1080_17489539_2020_1738625
crossref_primary_10_1186_s13023_021_02003_z
crossref_primary_10_1017_ipm_2017_23
crossref_primary_10_1080_09602011_2013_875043
crossref_primary_10_1080_09602011_2020_1838301
crossref_primary_10_1016_j_jpain_2021_10_003
crossref_primary_10_1136_bmjopen_2021_059152
crossref_primary_10_1097_HTR_0000000000000068
crossref_primary_10_1007_s11065_023_09607_1
crossref_primary_10_1017_BrImp_2017_34
crossref_primary_10_1177_0145445515593512
crossref_primary_10_1080_09602011_2015_1113997
crossref_primary_10_3758_s13428_013_0440_0
crossref_primary_10_1136_bmjopen_2023_073854
crossref_primary_10_1016_j_jbmt_2023_11_063
crossref_primary_10_1080_02699052_2018_1531313
crossref_primary_10_3310_hsdr08450
crossref_primary_10_5964_meth_9209
crossref_primary_10_1080_09602011_2024_2444999
crossref_primary_10_1016_j_rehab_2019_12_010
crossref_primary_10_1044_2024_AJSLP_23_00215
crossref_primary_10_1136_bmjopen_2020_041745
crossref_primary_10_1016_j_rehab_2021_101535
crossref_primary_10_1038_s41591_021_01519_y
crossref_primary_10_3389_fpsyg_2023_1195765
crossref_primary_10_1016_j_rehab_2023_101777
crossref_primary_10_1016_j_ridd_2018_05_008
crossref_primary_10_1016_j_psychsport_2019_101570
crossref_primary_10_1111_jsr_13843
crossref_primary_10_1371_journal_pone_0228077
crossref_primary_10_1080_09602011_2024_2331840
crossref_primary_10_1080_17549507_2022_2097310
crossref_primary_10_1080_09602011_2015_1102746
crossref_primary_10_1016_j_apmr_2015_08_424
crossref_primary_10_1007_s10488_024_01363_5
crossref_primary_10_1111_cp_12118
crossref_primary_10_1080_09638288_2020_1780637
crossref_primary_10_1136_bmjopen_2022_071262
crossref_primary_10_1007_s40614_020_00263_x
crossref_primary_10_1080_09638288_2021_1925752
crossref_primary_10_1080_09602011_2016_1140657
crossref_primary_10_1080_09638288_2021_1989062
crossref_primary_10_1177_0145445518806867
crossref_primary_10_1080_09602011_2020_1842214
crossref_primary_10_1136_bmjopen_2021_060206
crossref_primary_10_1002_ejp_1631
crossref_primary_10_1111_jir_12780
crossref_primary_10_1080_17489539_2022_2040164
crossref_primary_10_1002_jaba_923
crossref_primary_10_1080_09638288_2016_1219400
crossref_primary_10_1016_j_jcomdis_2016_02_004
crossref_primary_10_1016_j_prps_2019_03_001
crossref_primary_10_3233_NRE_161342
crossref_primary_10_3109_17518423_2015_1100688
crossref_primary_10_3390_nu16142243
crossref_primary_10_1080_19404158_2019_1596138
crossref_primary_10_1177_1558689818789530
crossref_primary_10_1080_13854046_2013_873083
crossref_primary_10_1017_BrImp_2018_9
crossref_primary_10_1212_WNL_0000000000011603
crossref_primary_10_1016_j_jvoice_2023_10_033
crossref_primary_10_1080_09602011_2020_1786410
crossref_primary_10_1136_bmjopen_2023_081571
crossref_primary_10_1016_j_apmr_2019_05_023
crossref_primary_10_1097_HTR_0000000000000942
crossref_primary_10_1111_aas_14295
crossref_primary_10_1007_s10567_023_00432_9
crossref_primary_10_1016_j_rehab_2017_12_002
crossref_primary_10_1044_2017_AJSLP_16_0197
crossref_primary_10_3233_NRE_161347
crossref_primary_10_1080_17518423_2019_1645226
crossref_primary_10_1177_0145445516664307
crossref_primary_10_3109_17549507_2014_979880
crossref_primary_10_2196_10451
crossref_primary_10_1080_09602011_2022_2053169
crossref_primary_10_1007_s40489_023_00371_9
crossref_primary_10_1080_09602011_2018_1433049
crossref_primary_10_1080_09602011_2022_2070506
crossref_primary_10_1016_j_apmr_2016_03_023
crossref_primary_10_1089_neur_2024_0076
crossref_primary_10_3390_jcm11123525
crossref_primary_10_2196_35884
crossref_primary_10_1080_1750984X_2023_2258383
crossref_primary_10_1177_14713012251323941
crossref_primary_10_3758_s13428_020_01417_0
crossref_primary_10_3389_fonc_2015_00071
crossref_primary_10_1016_j_jclinepi_2016_03_023
crossref_primary_10_1007_s40732_020_00402_5
crossref_primary_10_1080_09602011_2022_2107545
crossref_primary_10_1080_02687038_2020_1812031
crossref_primary_10_3389_fnhum_2016_00562
crossref_primary_10_1016_j_conctc_2021_100715
crossref_primary_10_1080_09602011_2023_2190129
crossref_primary_10_1177_0145445519854323
crossref_primary_10_1080_09602011_2022_2111314
crossref_primary_10_1016_j_jclinepi_2015_05_004
crossref_primary_10_1186_s13063_022_06968_5
crossref_primary_10_1177_0741932516652893
crossref_primary_10_1177_0741932517716899
crossref_primary_10_1080_21642850_2019_1711096
crossref_primary_10_1017_BrImp_2014_25
crossref_primary_10_1017_S1352465820000788
crossref_primary_10_1017_BrImp_2014_28
crossref_primary_10_1136_bmjopen_2022_067593
crossref_primary_10_1080_17489539_2016_1190525
crossref_primary_10_3390_ijerph19031509
crossref_primary_10_3758_s13428_020_01502_4
crossref_primary_10_1044_2020_AJSLP_20_00131
crossref_primary_10_1016_j_conctc_2021_100826
crossref_primary_10_1080_02687038_2023_2282659
crossref_primary_10_1080_09638288_2022_2138573
crossref_primary_10_3109_09638288_2016_1141241
crossref_primary_10_1080_09602011_2020_1768127
crossref_primary_10_1080_09602011_2021_1971094
crossref_primary_10_1352_1944_7558_126_2_114
crossref_primary_10_1016_j_jclinepi_2015_05_018
crossref_primary_10_1016_j_prps_2018_11_001
crossref_primary_10_1016_j_jcbs_2024_100801
crossref_primary_10_1177_0308022616640299
crossref_primary_10_1080_17489539_2019_1597444
crossref_primary_10_1016_j_beth_2016_04_008
crossref_primary_10_1044_2018_JSLHR_L_18_0057
crossref_primary_10_1097_HTR_0000000000000580
crossref_primary_10_1111_1460_6984_12841
crossref_primary_10_3758_s13428_020_01345_z
Cites_doi 10.1080/09602010343000182
10.1080/07434619412331276920
10.1007/s10864-006-9036-4
10.1177/0741932512452794
10.1177/001440290507100203
10.1080/10413200.2012.720640
10.1901/jaba.1982.15-477
10.1375/brim.12.1.33
10.1016/j.jclinepi.2008.10.009
10.3109/00365528809099154
10.1080/09602010802009201
10.1177/002221949302601001
10.1080/09602010903040691
10.1056/NEJM198604033141406
10.7326/0003-4819-112-4-293
10.3758/s13428-011-0111-y
10.1136/bmj.39590.732037.47
10.1111/j.1752-7325.2011.00233.x
10.1007/s11065-006-9013-7
10.1037/0022-0167.34.4.437
10.1037/1040-3590.6.4.284
10.1016/j.jclinepi.2010.03.004
10.1016/j.jclinepi.2003.12.010
10.1177/1053815111418235
10.1177/0741932512468038
10.1037/0022-006X.73.5.852
10.1371/journal.pmed.0040061
10.1016/j.jsp.2011.05.001
10.1037/a0017736
10.1097/00002060-199903000-00022
10.1089/acm.2004.10.979
10.1093/ptj/83.8.713
10.1901/jaba.1977.10-349
ContentType Journal Article
Copyright Copyright Taylor & Francis Group, LLC 2013
2015 INIST-CNRS
Copyright Taylor & Francis Group, LLC
Copyright_xml – notice: Copyright Taylor & Francis Group, LLC 2013
– notice: 2015 INIST-CNRS
– notice: Copyright Taylor & Francis Group, LLC
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QJ
7TK
7TS
K9.
NAPCQ
7X8
DOI 10.1080/09602011.2013.824383
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Applied Social Sciences Index & Abstracts (ASSIA)
Neurosciences Abstracts
Physical Education Index
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Applied Social Sciences Index and Abstracts (ASSIA)
Neurosciences Abstracts
Physical Education Index
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Applied Social Sciences Index and Abstracts (ASSIA)
ProQuest Health & Medical Complete (Alumni)

Neurosciences Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1464-0694
EndPage 638
ExternalDocumentID 3078877891
24050810
27801078
10_1080_09602011_2013_824383
824383
Genre Journal Article
GroupedDBID ---
.7I
.QK
0BK
0R~
123
29N
2QV
36B
4.4
5VS
AAGZJ
AAMFJ
AAMIU
AAPUL
AATTQ
AAWTL
AAZMC
ABCCY
ABDBF
ABFIM
ABIVO
ABJNI
ABLIJ
ABPEM
ABRYG
ABTAI
ABXUL
ABXYU
ABZLS
ACGEJ
ACGFO
ACGFS
ACPRK
ACTIO
ACTOA
ACUHS
ADAHI
ADCVX
ADKVQ
ADXPE
AECIN
AEGXH
AEISY
AEKEX
AENEX
AEOZL
AEPSL
AEYOC
AEZRU
AFHDM
AGDLA
AGMYJ
AGRBW
AHDZW
AHMBA
AIAGR
AIJEM
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AVBZW
AWYRJ
BEJHT
BLEHA
BMOTO
BOHLJ
CCCUG
CQ1
CS3
DGFLZ
DKSSO
DU5
DXH
EAP
EBD
EBS
EJD
EMK
EPL
EPS
ESX
E~B
E~C
F5P
FEDTE
FMBMU
FXNIP
G-F
GTTXZ
H13
HF~
HVGLF
HZ~
IPNFZ
J.O
KRBQP
KSSTO
KWAYT
KYCEM
LGLTD
M4Z
MLAFT
NA5
NW-
O9-
P2P
PQQKQ
RIG
RNANH
ROSJB
RSYQP
S-F
STATR
TBQAZ
TEH
TFH
TFL
TFW
TNTFI
TRJHH
TUROJ
UT5
UT9
VAE
~01
~S~
.GJ
07M
1TA
4B3
53G
AAGDL
AAHIA
AANPH
AAYXX
ABVXC
ABWZE
ACIKQ
ACPKE
ACRBO
ADEWX
ADIUE
ADXAZ
ADYSH
AEFOU
AEXSR
AFRVT
AIXGP
AIYEW
ALLRG
AMPGV
C5A
CAG
CBZAQ
CITATION
CKOZC
COF
C~T
DGXZK
EFRLQ
EGDCR
JLMOS
L7Y
LJTGL
QZZOY
RBICI
TBH
TDBHL
UA1
ZY4
AAAVI
ABJVF
ABPTK
ABPTX
ABQHQ
ABSSG
ABTAH
ACLSK
AEGYZ
AFOLD
AFWLO
FUNRP
IQODW
KDLKA
V1K
CGR
CUY
CVF
ECM
EIF
NPM
TASJS
7QJ
7TK
7TS
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c487t-3618d7c107476710a5942241fed09fe6204edeccae43142257dbbd63c0f529b93
ISSN 0960-2011
1464-0694
IngestDate Fri Jul 11 09:25:29 EDT 2025
Fri Jul 11 01:09:39 EDT 2025
Mon Jul 21 11:12:10 EDT 2025
Sat Jul 26 02:08:15 EDT 2025
Mon Jul 21 05:48:25 EDT 2025
Sun Oct 22 16:07:57 EDT 2023
Thu Apr 24 23:07:07 EDT 2025
Tue Jul 01 00:35:02 EDT 2025
Wed Dec 25 09:01:39 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Human
Methodology
Evaluation scale
M-of-1 trial
Evidence-based practice
Internal validity
Single-case experimental design
Experimental study
Evidence-based medicine
Case study
Validity
Treatment
Risk of bias
Experimental design
Quality
Risk factor
Methodological bias
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c487t-3618d7c107476710a5942241fed09fe6204edeccae43142257dbbd63c0f529b93
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 24050810
PQID 1434760419
PQPubID 436415
PageCount 20
ParticipantIDs proquest_miscellaneous_1464512885
proquest_journals_1434760419
crossref_primary_10_1080_09602011_2013_824383
pubmed_primary_24050810
proquest_miscellaneous_1434742049
pascalfrancis_primary_27801078
informaworld_taylorfrancis_310_1080_09602011_2013_824383
proquest_miscellaneous_1512191891
crossref_citationtrail_10_1080_09602011_2013_824383
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-10-01
PublicationDateYYYYMMDD 2013-10-01
PublicationDate_xml – month: 10
  year: 2013
  text: 2013-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Hove
PublicationPlace_xml – name: Hove
– name: England
PublicationTitle Neuropsychological rehabilitation
PublicationTitleAlternate Neuropsychol Rehabil
PublicationYear 2013
Publisher Routledge
Psychology Press
Taylor & Francis Ltd
Publisher_xml – name: Routledge
– name: Psychology Press
– name: Taylor & Francis Ltd
References CIT0030
CIT0010
CIT0032
CIT0012
CIT0034
CIT0033
Hersen M. (CIT0019) 1976
Maher C. G. (CIT0031) 2003; 83
Guyatt G. (CIT0017) 1988; 139
Tate R. (CIT0044)
CIT0014
Howick J. (CIT0022) 2011
CIT0036
CIT0035
CIT0016
CIT0038
CIT0037
CIT0018
CIT0039
Barlow D. H. (CIT0003) 1984
Gast D. L. (CIT0013) 2010
CIT0040
CIT0043
Kazdin A. E. (CIT0025) 2011
CIT0042
CIT0023
CIT0045
Higgins J. P. T. (CIT0020) 2011
Barlow D. H. (CIT0004) 2009
Guyatt G. (CIT0015) 2002
Horner R. H. (CIT0021) 2005; 71
Kazdin A. E. (CIT0024) 1982
Anastasi A. (CIT0001) 1997
CIT0047
CIT0002
CIT0046
CIT0005
CIT0027
CIT0026
CIT0048
CIT0007
CIT0029
CIT0006
CIT0028
CIT0009
CIT0008
References_xml – ident: CIT0043
  doi: 10.1080/09602010343000182
– volume-title: Single case experimental designs: Strategies for studying behavior for change
  year: 2009
  ident: CIT0004
– volume: 139
  start-page: 497
  year: 1988
  ident: CIT0017
  publication-title: Canadian Medical Association Journal
– volume-title: Cochrane handbook for systematic reviews of interventions
  year: 2011
  ident: CIT0020
– volume-title: Single subject research methodology in behavioural sciences
  year: 2010
  ident: CIT0013
– ident: CIT0037
  doi: 10.1080/07434619412331276920
– volume-title: BEhavioural interventions (SCRIBE): Explanation and elaboration
  ident: CIT0044
– ident: CIT0030
  doi: 10.1007/s10864-006-9036-4
– ident: CIT0028
  doi: 10.1177/0741932512452794
– volume: 71
  start-page: 165
  issue: 2
  year: 2005
  ident: CIT0021
  publication-title: Exceptional Children
  doi: 10.1177/001440290507100203
– volume-title: Single-case research designs. Methods for clinical and applied settings
  year: 2011
  ident: CIT0025
– start-page: 179
  volume-title: User's guides to the medical literature
  year: 2002
  ident: CIT0015
– ident: CIT0033
  doi: 10.1080/10413200.2012.720640
– ident: CIT0027
– volume-title: Psychological Testing
  year: 1997
  ident: CIT0001
– ident: CIT0036
  doi: 10.1901/jaba.1982.15-477
– ident: CIT0045
  doi: 10.1375/brim.12.1.33
– volume-title: Single case research designs: Methods for clinical and applied settings
  year: 1982
  ident: CIT0024
– ident: CIT0039
  doi: 10.1016/j.jclinepi.2008.10.009
– ident: CIT0026
  doi: 10.3109/00365528809099154
– volume-title: The 2011 Oxford CEBM Evidence Table (Introductory Document)
  year: 2011
  ident: CIT0022
– ident: CIT0042
  doi: 10.1080/09602010802009201
– ident: CIT0048
  doi: 10.1177/002221949302601001
– ident: CIT0035
  doi: 10.1080/09602010903040691
– ident: CIT0018
  doi: 10.1056/NEJM198604033141406
– ident: CIT0016
  doi: 10.7326/0003-4819-112-4-293
– ident: CIT0038
  doi: 10.3758/s13428-011-0111-y
– ident: CIT0014
  doi: 10.1136/bmj.39590.732037.47
– ident: CIT0006
  doi: 10.1111/j.1752-7325.2011.00233.x
– volume-title: Single case experimental designs: Strategies for studying behavior for change
  year: 1984
  ident: CIT0003
– ident: CIT0005
  doi: 10.1007/s11065-006-9013-7
– ident: CIT0012
  doi: 10.1037/0022-0167.34.4.437
– ident: CIT0010
  doi: 10.1037/1040-3590.6.4.284
– ident: CIT0034
  doi: 10.1016/j.jclinepi.2010.03.004
– ident: CIT0009
  doi: 10.1016/j.jclinepi.2003.12.010
– ident: CIT0047
  doi: 10.1177/1053815111418235
– ident: CIT0046
  doi: 10.1177/0741932512468038
– ident: CIT0007
  doi: 10.1037/0022-006X.73.5.852
– ident: CIT0008
  doi: 10.1371/journal.pmed.0040061
– ident: CIT0032
  doi: 10.1016/j.jsp.2011.05.001
– ident: CIT0029
  doi: 10.1037/a0017736
– ident: CIT0002
  doi: 10.1097/00002060-199903000-00022
– ident: CIT0023
  doi: 10.1089/acm.2004.10.979
– volume: 83
  start-page: 713
  year: 2003
  ident: CIT0031
  publication-title: Physical Therapy
  doi: 10.1093/ptj/83.8.713
– volume-title: Single case experimental designs: Strategies for studying behaviour change
  year: 1976
  ident: CIT0019
– ident: CIT0040
  doi: 10.1901/jaba.1977.10-349
SSID ssj0018046
Score 2.4898884
Snippet Recent literature suggests a revival of interest in single-case methodology (e.g., the randomised n-of-1 trial is now considered Level 1 evidence for treatment...
SourceID proquest
pubmed
pascalfrancis
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 619
SubjectTerms Bias
Biological and medical sciences
Data Interpretation, Statistical
Evidence-based medicine
Humans
Internal validity
Medical sciences
Methodology
Miscellaneous
n-of-1 trial
Novices
Psychology. Psychoanalysis. Psychiatry
Psychometric properties
Psychometrics - methods
Psychopathology. Psychiatry
Randomized Controlled Trials as Topic - methods
Ratings & rankings
Research Design
Revisions
Revival
Risk of bias
Single-case experimental design
Techniques and methods
Validity
Title Revision of a method quality rating scale for single-case experimental designs and n-of-1 trials: The 15-item Risk of Bias in N-of-1 Trials (RoBiNT) Scale
URI https://www.tandfonline.com/doi/abs/10.1080/09602011.2013.824383
https://www.ncbi.nlm.nih.gov/pubmed/24050810
https://www.proquest.com/docview/1434760419
https://www.proquest.com/docview/1434742049
https://www.proquest.com/docview/1464512885
https://www.proquest.com/docview/1512191891
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVEJcEG8CpVokDqBoq6yfa24tD1WI5hASUXGx_FhLUVM7SpND-Sn8FH4dMzvr2BZteFwsyzv2Wp7PszOz82DsVZrKUGeOxijxUHhRlgtY9LRIQJ2QrpcXrsJ859NxcDLzPp35Z73ez1bU0madHmbfr80r-R-uwjXgK2bJ_gNntw-FC3AO_IUjcBiOf8XjiU0NpyRHagZt0ySvhsha9BUAE6iwN3oFFlpksG51C_vnJoqDijWXoiqEHJpmHpd10If0Bfp4hxMbh348T0wY7ZiIp4aYnBHH8_EUPQ1fcNq25muqgCw74nbVqRLe-BCoY9-kSq_K4edGdgOUrVBrx_on1B2yPK9MYhIOzxar-Xmz5wQ68gXZCiW1Cq-9HLKJl4NFiiSzF3gCs3TboptSlS1E_ZYcDkgO_7Y-2IBKMNtM8Vac6VA5WK61TQ5fd3lhMAP6DmiwNvC2W5e7HrrF9hwwUZw-2zs6ef_t63YPS428oE7WxGru10yKpajtYzp6UadqLobrJgiWglqt3GwLGZ1oeo_dtcYMPyJk3mc9XT5gt09tuMZD9qMGKK8KnnACKLcA5QRQbgDK4UV4C6C8DVBuAcoBoJwAygmgbznAk1t4coQnzoTw5POSEzw5wZO_JnC-4Qaaj9js44fpuxNhm4GIDGzqtXADqfIww_jhMAC1OPEjD9XPQuejqNDYVkHnKI80qMQw4od5muaBm40K34nSyH3M-mVV6qeMK0dlMJwoKTMvwXpNoMaHShZRIp1MuwPm1qyIM_sPYMOWRSzrgrqWlzHyMiZeDpjY3rWkSjF_oFdtLsdr46GzPI7d3bcedBCxnc8JQeEEpX_A9muIxFZeXYKR78KnG3kyGrCX22FYTXCLMCl1tbE0HnzLnTSBB2aCUv4OGiAAYa8iOWBPCKLNS1rEP7tx5Dm708iAfdZfrzb6Bej-6_TA_mS_AASY-5U
linkProvider Library Specific Holdings
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaglaAX3o9AKYPEAQ5e4jgPhxtFVKF097BsJW5R4jho1SqpSPYAP4Vfy0zsLF2kLhJccvE4jidj-xt7_A1jL8tSJEYHhqLEEx6muuK46BleIJwQMqxqqei-83QWZ6fh8ZdojCbsXFgl-dC1JYoY5moa3LQZPYbEvSHYPZBv4kNOVEB0m9fZbpSGEv2v3cX8OMvWRwnKt7d1sA6nSuP9uSves7E-bbCXUthk0aHmapvy4mpMOqxNR7dZOfbKhqScTVZ9OdE__iB8_K9u32G3HHKFd9bU7rJrprnHbkzd2fx99nPuLqpDW0MBNjU12Eub34EMrfkK1DED2FugPYpzwzWuonA5zQBUQ0xJB_id0PC25gKG1CLdW0CbBhFx2m-G-bI7o5YOl0UHywZmVnQxiMKreXu4nC1ew2dq8AE7PfqweJ9xl_mBa3Sgei5joapEU7BoEiMGKvDXEtaoTeWntSEOfVOR8RnEP1gSJVVZVrHUfh0FaZnKh2ynaRvzmAF6lBqLCyWEDgsi50HMlihRp4UItJEek-P_zrWjRafsHOe5GNlTndpzUntu1e4xvq51YWlB_iKvLptS3g_bMc6Qcrm96sGG2a3bCxJEF4jwPLY_2mHuJqAOPTqJqvNDkXrsxboYpw46Dyoa066cTIi63CoTh4gJlYq2yKAAjmyVCo89suPg90eiQ4Co03_y7wp4zm5mi-lJfvJx9ukp26MSG025z3b6byvzDFFhXx64cf8LVPpP7g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaglSouvB-BUgaJAxy8jfN0uFFgtRS6QstW6i1KHButWiUVyR7gp_BrmYmdZRepiwSXHNbjOJ4d25_tmW8Ye1GWItUq0OQlnvIoUxXHRU_zAuGECKPKhJLinU-myeQ0Oj6Lz9ai-MmtkvbQxhJF9HM1De7LygwecYeEunvuTXyEIxkQ2-Z1tos_Bmjju_PZ8WSyukmQvg3WwTqcKg3hc1e8Z2N52iAvJa_JokXFGZvx4mpI2i9N41usGDplPVLOR8uuHKkff_A9_k-vb7ObDrfCG2tod9g1Xd9leyfuZv4e-zlzYerQGCjAJqYGG7L5HcjM6q9A_dKAnQU6objQXOEaCutJBqDqPUpawM-EmjeGC-gTi7SvAS0aRMzptBlmi_acWjpaFC0sapha0XkvCi9nzdFiOn8FX6jB--x0_H7-dsJd3geucPvU8TARskoVuYqmCSKgIs4iQhpGV35mNDHo64pMTyP6wZI4rcqySkLlmzjIyix8wHbqptaPGOB-UmFxIYVQUUHUPIjYUilMVohA6dBj4fB358qRolNujotcDNypTu05qT23avcYX9W6tKQgf5GX65aUd_1hjLOjPNxe9WDD6lbtBSliC8R3HtsfzDB300-L-7kQVedHIvPY81UxThx0G1TUulk6mQh1uVUmiRARShlvkUEBHNcyEx57aIfB74_E7QBiTv_xvyvgGdv7_G6cf_ow_fiE3aAC60q5z3a6b0v9FCFhVx64Uf8L29NOkg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Revision+of+a+method+quality+rating+scale+for+single-case+experimental+designs+and+n-of-1+trials%3A+the+15-item+Risk+of+Bias+in+N-of-1+Trials+%28RoBiNT%29+Scale&rft.jtitle=Neuropsychological+rehabilitation&rft.au=Tate%2C+Robyn+L&rft.au=Perdices%2C+Michael&rft.au=Rosenkoetter%2C+Ulrike&rft.au=Wakim%2C+Donna&rft.date=2013-10-01&rft.eissn=1464-0694&rft.volume=23&rft.issue=5&rft.spage=619&rft_id=info:doi/10.1080%2F09602011.2013.824383&rft_id=info%3Apmid%2F24050810&rft.externalDocID=24050810
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-2011&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-2011&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-2011&client=summon